Management of Non-Cystic Fibrosis Bronchiectasis

被引：0
|
作者：
Dull, Stacey K. [1 ]
Havlat, Brooke D. [2 ]
Sanley, Michael J. [3 ]
Malesker, Mark A. [4 ]
机构：
[1] Creighton Univ, Sch Pharm & Hlth Profess, Pharm Practice, 2500 Calif Plaza, Omaha, NE 68178 USA
[2] Madonna Rehabil Hosp, Omaha, NE USA
[3] Creighton Univ, Sch Med, Div Pulm Crit Care & Sleep Med, Med, Omaha, NE 68178 USA
[4] Creighton Univ, Sch Med, Pharm Practice & Med, Omaha, NE 68178 USA
来源：
CONSULTANT PHARMACIST | 2018年 / 33卷 / 11期
关键词：
Airway clearance; Bronchiectasis; Hyperosmolar agents; Inhaled antibiotics; Macrolides; Mucolytic agents;
D O I：
10.4140/TCP.n.2018.658
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
OBJECTIVE: The purpose of this report is to describe the case of a 43-year-old male with asthma who was hospitalized for an exacerbation of non-cystic fibrosis bronchiectasis (NCFB), a chronic lung disease that is characterized by dilation of the airways, persistent cough, chronic sputum production, and recurrent respiratory infections. He was treated with oral and inhaled antibiotics, inhaled bronchodilators, and aggressive airway-clearance techniques including nebulized 7% sodium chloride, flutter valve, and high-frequency chest wall oscillation. SETTINGS: Community pharmacy, nursing facility pharmacy, consultant pharmacy practice. PRACTICE CONSIDERATIONS: As the number of patients diagnosed with NCFB continues to increase, it is crucial to recognize that specific guidance for management of NCFB is warranted, as treatment responses differ from cystic fibrosis bronchiectasis or chronic obstructive pulmonary disease. CONCLUSION: It is important for pharmacists to understand the pharmacologic and nonpharmacologic treatments for NCFB to better assist physicians and patients and improve therapeutic outcomes.
引用
收藏
页码：658 / 666
页数：9
相关论文
共 50 条
  • [1] Management of non-cystic fibrosis bronchiectasis
    Webb, Philip
    King, Jenny
    Baxter, Caroline
    Lord, Robert W.
    [J]. BRITISH JOURNAL OF HOSPITAL MEDICINE, 2021, 82 (07)
  • [2] Diagnosis and management of non-cystic fibrosis bronchiectasis
    Macfarlane, Laura
    Kumar, Kartik
    Scoones, Thomas
    Jones, Andrew
    Loebinger, Michael R.
    Lord, Robert
    [J]. CLINICAL MEDICINE, 2021, 21 (06) : E571 - E577
  • [3] Etiopathogenesis and management of non-cystic fibrosis bronchiectasis
    Mathioudakis, A. G.
    Mathioudakis, G. A.
    [J]. ARCHIVES OF HELLENIC MEDICINE, 2015, 32 (02): : 135 - 148
  • [4] Surgical management of non-cystic fibrosis bronchiectasis
    Hiramatsu, Miyako
    Shiraishi, Yuji
    [J]. JOURNAL OF THORACIC DISEASE, 2018, 10 : S3436 - S3445
  • [5] Non-cystic fibrosis bronchiectasis
    McDonnell, M. J.
    Ward, C.
    Lordan, J. L.
    Rutherford, R. M.
    [J]. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2013, 106 (08) : 709 - 715
  • [6] Non-cystic fibrosis bronchiectasis
    Al Subie, Haya
    Fitzgerald, Dominic A.
    [J]. JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2012, 48 (05) : 382 - 388
  • [7] Non-cystic fibrosis bronchiectasis
    Neves, Paulo C.
    Guerra, Miguel
    Ponce, Paulo
    Miranda, Jose
    Vouga, Luis
    [J]. INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2011, 13 (06) : 619 - 625
  • [8] Non-cystic fibrosis bronchiectasis
    Murray, Maeve P.
    Hill, Adam T.
    [J]. CLINICAL MEDICINE, 2009, 9 (02): : 164 - 169
  • [9] Non-cystic fibrosis bronchiectasis
    Smith, M. P.
    [J]. JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH, 2011, 41 (02): : 132 - 139
  • [10] Non-cystic fibrosis bronchiectasis
    Cowie, Robert
    Field, Stephen
    [J]. CLINICAL MEDICINE, 2009, 9 (04) : 401 - 402
12345